INEGY 10 MG80 MG TABLETS

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

EZETIMIBE; SIMVASTATIN

Доступна з:

MERCK SHARP & DOHME ISRAEL LTD

Код атс:

C10AA01

Фармацевтична форма:

TABLETS

Склад:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Адміністрація маршрут:

PER OS

Тип рецепту:

Required

Виробник:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Терапевтична група:

SIMVASTATIN

Терапевтична области:

SIMVASTATIN

Терапевтичні свідчення:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Дата Авторизація:

2012-04-30